- Home
- Publications
- Publication Search
- Publication Details
Title
Updates on obesity pharmacotherapy
Authors
Keywords
-
Journal
Annals of the New York Academy of Sciences
Volume 1411, Issue 1, Pages 106-119
Publisher
Wiley
Online
2018-01-30
DOI
10.1111/nyas.13542
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardiovascular safety of empagliflozin in patients with type 2 diabetes: a meta-analysis of data from randomized placebo-controlled trials
- (2016) A. Salsali et al. DIABETES OBESITY & METABOLISM
- Obesity: Guidelines, Best Practices, New Research
- (2016) Caroline M. Apovian et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Efficacy for Psychopathology and Body Weight and Safety of Topiramate-Antipsychotic Cotreatment in Patients With Schizophrenia Spectrum Disorders
- (2016) Christoph U. Correll et al. JOURNAL OF CLINICAL PSYCHIATRY
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low adoption of weight loss medications: A comparison of prescribing patterns of antiobesity pharmacotherapies and SGLT2s
- (2016) Catherine E. Thomas et al. Obesity
- Metformin versus placebo in combination with insulin analogues in patients with type 2 diabetes mellitus—the randomised, blinded Copenhagen Insulin and Metformin Therapy (CIMT) trial
- (2016) Louise Lundby-Christensen et al. BMJ Open
- ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies
- (2015) Barham K. Abu Dayyeh et al. GASTROINTESTINAL ENDOSCOPY
- Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes
- (2015) Melanie J. Davies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
- (2015) Caroline M. Apovian et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Drugs Commonly Associated With Weight Change: A Systematic Review and Meta-analysis
- (2015) Juan Pablo Domecq et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of obesity: Pharmacotherapy trends in the United States from 1999 to 2010
- (2015) Ying Xia et al. Obesity
- Challenging obesity: Patient, provider, and expert perspectives on the roles of available and emerging nonsurgical therapies
- (2015) Caroline M. Apovian et al. Obesity
- Intermittent Vagal Nerve Block for Improvements in Obesity, Cardiovascular Risk Factors, and Glycemic Control in Patients with Type 2 Diabetes Mellitus: 2-Year Results of the VBLOC DM2 Study
- (2015) Scott A. Shikora et al. OBESITY SURGERY
- Weight Regain After Gastric Bypass: Influence of Gut Hormones
- (2015) Marco Aurelio Santo et al. OBESITY SURGERY
- Safety and Efficacy of Contraceptive Methods for Obese and Overweight Women
- (2015) Pamela S. Lotke et al. OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA
- Update on obesity pharmacotherapy
- (2014) George A. Bray et al. Annals of the New York Academy of Sciences
- Obesity Begets Atrial Fibrillation
- (2013) Jared W. Magnani et al. CIRCULATION
- Echocardiographic Assessment of Cardiac Valvular Regurgitation With Lorcaserin From Analysis of 3 Phase 3 Clinical Trials
- (2013) Neil J. Weissman et al. Circulation-Cardiovascular Imaging
- Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes
- (2013) P. Hollander et al. DIABETES CARE
- Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults
- (2013) J van Can et al. INTERNATIONAL JOURNAL OF OBESITY
- Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study
- (2013) T A Wadden et al. INTERNATIONAL JOURNAL OF OBESITY
- Long-term Drug Treatment for Obesity
- (2013) Susan Z. Yanovski et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
- (2013) Paul A. James et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Training Physicians to Manage Obesity — Back to the Drawing Board
- (2013) James A. Colbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Why do we need drugs to treat the patient with obesity?
- (2013) George A. Bray Obesity
- Evaluation of phentermine and topiramate versus phentermine/topiramate extended-release in obese adults
- (2013) Louis J. Aronne et al. Obesity
- A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II)
- (2013) Caroline M. Apovian et al. Obesity
- Use of Prescription Antiobesity Drugs in the United States
- (2013) Christian Hampp et al. PHARMACOTHERAPY
- Management of Obesity in the National Health and Nutrition Examination Survey (NHANES), 2007–2008
- (2012) Nithushi R. Samaranayake et al. ANNALS OF EPIDEMIOLOGY
- Obesity and Cardiovascular Disease
- (2012) Caroline M. Apovian et al. CIRCULATION
- Morbid obesity rates continue to rise rapidly in the United States
- (2012) R Sturm et al. INTERNATIONAL JOURNAL OF OBESITY
- Randomized Placebo-Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM-DM Study
- (2012) Patrick M. O'Neil et al. Obesity
- Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
- (2011) W Timothy Garvey et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial
- (2011) Meredith C. Fidler et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
- (2011) Kishore M Gadde et al. LANCET
- Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)
- (2011) David B. Allison et al. Obesity
- Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2010) Frank L Greenway et al. LANCET
- Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management
- (2010) Steven R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial
- (2010) Thomas A. Wadden et al. Obesity
- Rational Design of a Combination Medication for the Treatment of Obesity
- (2008) Frank L. Greenway et al. Obesity
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now